SURECAN: Survivors rehabilitation evaluation after cancer

Not Applicable

• Conditions: Mental health, quality of life in cancer survivors; Mental and Behavioural Disorders

• Registration Number: ISRCTN67900293
• Lead Sponsor: Queen Mary University of London

Brief Summary

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38566197/ (added 03/04/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-09
• Last Update Posted: 15 April 2024
• Study Completion: 2025-04-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 344

Inclusion Criteria

Current inclusion criteria as of 28/11/2023:

1. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, lower gastro-intestinal cancer, urological cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
2. Aged 18 years or over
3. Participant’s GP practice falls within a participating IAPT service catchment, or if other psychological service provider, participant resides within their catchment area
4. Ability to give informed consent
5. Sufficient fluency in spoken English to be able to participate in a talking-based therapy delivered in English
6. With a score of 78 or less on the Functional Assessment of Cancer Therapy – General (FACT-G)

_____

Previous inclusion criteria:

1. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, colorectal cancer, prostate cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
2. Aged 18 years or over
3. Participant’s GP practice falls within a participating IAPT service catchment, or if other psychological service provider, participant resides within their catchment area
4. Ability to give informed consent
5. Sufficient fluency in spoken English to be able to participate in a talking-based therapy delivered in English
6. With a score of 78 or less on the Functional Assessment of Cancer Therapy – General (FACT-G)

Exclusion Criteria

Current exclusion criteria as of 28/11/2023:

1. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long-term, ongoing maintenance treatment e.g. androgen suppression therapy in urological cancer)
2. Receiving palliative or terminal care
3. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)
4. Other serious co-morbid condition which would make it difficult for the participant to receive a talking-based one-to one intervention
5. Require urgent psychiatric or clinical psychology assessment

_____

Previous exclusion criteria:

1. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long-term, ongoing maintenance treatment e.g. androgen suppression therapy in prostate cancer)
2. Receiving palliative or terminal care
3. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)
4. Other serious co-morbid condition which would make it difficult for the participant to receive a talking-based one-to one intervention
5. Require urgent psychiatric or clinical psychology assessment

Study & Design

• Study Type: Interventional
• Study Design: Not specified